By
Latest Stories
Don’t miss our hot and upcoming stories
Pfizer Expands Deal to $610M, AI Drug Discovery Partnership with PostEra to Advance Small Molecules and ADCs
Boston – Jan 7, 2025 Strengthening AI-Driven Innovation in Small Molecules and ADCs Pfizer has…
Terray’s AI-Driven Drug Discovery Platform Secures Collaboration with Gilead
Boston – Dec 17, 2024 Strategic Expansion Following $120M Series B Terray Therapeutics is closing…
Unlearn AI’s Breakthroughs in AI-Driven Clinical Development: 2024 Milestones and Future Outlook
San Francisco – December 12, 2024 Unlearn AI has emerged as a leader in AI-powered…
How Unlearn AI Is Increasing the Efficiency of Phase 2 Clinical Trials with AI-Powered TwinRCT
December 11, 2024 Enhanced TwinRCT™ 3.0 Unlearn® has introduced an upgraded version of its AI-driven…